Testing effectiveness (Phase 2)Ended earlyNCT03004001
What this trial is testing
Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome
Who this might be right for
Nephrotic Syndrome
Gloria Vega 3
Showing 20 of 0 results